A Study of MCARH109 and MCARH125 in People With Multiple Myeloma

NCT05431608 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

15

Enrollment

OTHER

Sponsor class

Conditions

Multiple Myeloma
Refractory Multiple Myeloma
Relapse Multiple Myeloma

Interventions

BIOLOGICAL: MCARH125
BIOLOGICAL: MCARH109

Sponsor

Memorial Sloan Kettering Cancer Center